46 • Comprehensive lactation support and counseling by a trained provider during pregnancy and/or in the postpartum period, and costs for renting breastfeeding equipment. The Plan may pay for purchase of lactation equipment instead of rental, if deemed appropriate by the Plan; • Cervical cancer screening for women ages 21 to 65 with Pap smear every three years; • Human papillomavi rus testing for women ages 30 and older with normal Pap smear results, once every three years as part of a well woman visit; • Chlamydia infection screening for all sexually active non - pregnant young women aged 24 and younger, and for older non - pregnant wome n who are at increased risk, as part of a well woman visit. • For all pregnant women aged 24 and younger, and for older pregnant women at increased risk, chlamydia infection screening is covered as part of the prenatal visit; • For women of reproductive capaci ty, the Plan will cover at least one form of contraception in each of the FDA - approved contraceptive methods (including barrier and hormonal methods and implanted devices) as well as patient education and counseling, when prescribed by a health care provid er. Services related to follow - up and management of side effects, counseling for continued adherence, and device removal are also covered without cost sharing. The FDA - approved contraception methods for women include : Sterilization surgery (tubal ligation) Surgical sterilization implant for women Implantable rod Intrauterine device (IUD) copper IUD with progestin Shot/injection Oral contraceptives (combined pill) Oral contraceptives (progestin pill) Oral contraceptives (extended/continuous use) Patch Vagina l contraceptive ring Diaphragm Sponge Cervical cap Female condom Spermicide Emergency Contraception (Plan B/Plan B One Step/Next Choice) Emergency Contraception (Ella) • Generic birth control prescriptions and brand name birth control prescriptions for which there is no generic equivalent; • The Plan may cover a generic drug without cost sharing but charge cost sharing for an equivalent branded drug. The Plan will accommodate any individual for whom the generic would be medically inappropriate, as determined by the individual’s health care provider and the Prescription Drug Coverage prior authorization process;
2018 BTF Plan B Page 50 Page 52